Take the innovative Giasay® PROSTATE test
Blood test with the highest accuracy of oncological risk assessment of prostate cancer.
One blood test will tell if your prostate is healthy.
It will distinguish benign prostate enlargement from oncological disease.
The test result will tell your urologist whether a biopsy is really necessary.
In the case of ongoing treatment, you will receive information about its success.
Where you can take the test
You can take the above-standard Giasay® PROSTATE blood test in selected urology clinics.
Using a reliable method for determining the correct diagnosis is important.
A standard prostate-specific antigen test (PSA) can be misrepresented for a variety of reasons. 3 out of 4 of all positive PSA tests are false positives, leading to the need for further examinations, including a prostate biopsy.
For this reason, new tests aimed at improving the diagnosis of prostate cancer have been put into practice, such as PHI – determination of the prostate health index or determination of the free-PSA (fPSA).
Giasay® PROSTATE is a new and unique test.
Validation studies performed in the European Union countries, including Slovakia, on 501 patients showed that the Giasay® PROSTATE test reliably detects 82 out of 100 cases of prostate cancer, including very early stages. In addition, a detailed evaluation of 392 patients showed that the Giasay® PROSTATE test can prevent prostate biopsies, which would end up negative in up to 73% of cases.
Prostate cancer is the most common oncological disease in men over the age of 50. It usually develops slowly and initially does not cause any health problems. A man usually feels the first symptoms only when the tumour presses on the bladder, which manifests itself as difficulty urinating, frequent urination, blood in the urine, pelvic pain and erectile dysfunction. Early and correct diagnosis of the disease significantly improves treatment and quality of life.
Do not be afraid
- It is recommended to undergo an oncological check-up of the prostate after the age of 45.
- The examination includes an interview with the patient, collection of a urine sample, examination of the prostate by palpation through the rectum, ultrasound of the excretory system and a blood test.
- A standard examination is the determination of the amount of prostate-specific antigen (PSA) in the blood.
- By completing the Giasay® PROSTATE above-standard examination, you will get comfort and reliable information about the health of your prostate.
The most frequently asked questions
The prostate (or the prostate gland) is a small, unpaired male organ located around the urethra just below the bladder, the enlargement of which often leads to problems with urination. The prostate produces a secretion that liquefies the ejaculate. A large number of men over 50 years of age experience a non-cancerous enlargement of the prostate (so-called benign hyperplasia), which has symptoms very similar to prostate cancer, so a reliable and timely diagnosis and differentiation of both diseases is necessary.
PSA (prostate specific antigen) is an enzyme that is found in all the secretions of the prostate and performs an important function in it. Its production in the body is almost exclusively limited to the prostate, production alone is not associated with the disease. However, its increased concentration in the blood indicates a problem with the prostate (benign enlargement, inflammation – so-called prostatitis, prostate tumours, but also, for example, long-term mechanical stimulation and routine activities such as cycling or sexual intercourse), which can lead to further examinations by a urologist to detect causes.
Most urological symptoms that appear suddenly are caused by a urinary tract infection. However, in case of any doubts or persistent problems, a urologist should be consulted. If you have no symptoms and you are at least 50 years old (or at least 45 years old if your family member was diagnosed with prostate cancer), you should undergo a preventive check-up by a urologist.
Prostate biopsy is currently the only gold standard that leads to the detection of prostate tumours. A biopsy is the collection of part of the prostate tissue (through the perineum, with the assistance of imaging methods), which is afterwards examined by a histologist. The histologist will determine whether a clinically significant tumour is present in the sample and whether intervention is necessary or further monitoring is sufficient.
The Giasay® PROSTATE test is primarily intended for men who have tPSA values in the range of 2-10 ng/ml and are interested in the so-called “second opinion test” when deciding on the next procedure in the diagnosis and therapy of prostate disease. The test can also be used in men over the age of 45 who are interested in a non-standard oncological prostate check-up. The test result is exclusively sent to the treating urologist who indicated the test and can also interpret the result.
To perform the Giasay® PROSTATE test, it is necessary to have a blood sample taken by a urologist. The results are usually available to the urologist within 7 – 10 days from the blood collection. The price for the test is EUR 250 and covers the logistics, processing and evaluation of the anonymized sample. It is also necessary for persons interested to have determined values of tPSA and fPSA% no older than 14 days when taking blood. Otherwise, blood is also taken for these markers, which are determined in commercial laboratories. The results of the test are always interpreted by the treating urologist who indicated the test.
The Giasay® PROSTATE test is unique in that it assesses a parameter specific to prostate carcinoma, providing the highest accuracy of prostate cancer risk assessment of available blood tests. In practice, this means that the test can more accurately distinguish benign prostate enlargement from oncological disease, thus helping the urologist to refine the next procedure, which also benefits the patient himself.
In three validation studies involving 501 patients, the Giasay® PROSTATE test demonstrated that the Giasay® test can reliably detect 82 out of 100 cases of prostate cancer, including very early stages. In addition, we work with the data that approximately 3 out of 4 biopsies end up negative. A biopsy is not pleasant and can carry certain risks, like any invasive procedure. The results so far show that the Giasay® PROSTATE test can prevent such interventions in 73% percent.
Like any laboratory method, the Giasay® PROSTATE test is not 100% accurate, which is not related to the test itself, but to the biological variability of each individual. Therefore, the test results are always interpreted by the attending urologist, who comprehensively assesses your state of health based on several examinations and suggests the best treatment procedure for you.
It is a good idea to repeat the Giasay® PROSTATE test in case of ambiguous or borderline values, or as part of the next preventive check-up by your urologist. Monitoring the time course of the measured values can provide information on the development of the given disease or the success of the ongoing treatment.
The Giasay® PROSTATE test is the result of long-term research by scientists from the Slovak Academy of Sciences – h olders of several domestic and foreign awards. Validation was carried out over several years in cooperation with clinical partners from several EU countries and using samples from hundreds of patients. The results of our work have appeared and continue to appear in international peer-reviewed scientific publications, and our employees regularly participate in scientific conferences, where our results are presented and discussed by experts in the field.
The Giasay® PROSTATE test cannot be performed independently. Its indication is decided by your doctor – urologist. You can take it directly at the outpatient clinic or surgery, where your blood will be taken. The analysis of the anonymized sample in the certified laboratory of the company Glycanostics® is usually evaluated within 7 – 10 days from blood collection. Afterwards, your doctor – urologist will inform you about the results of the test.